Business Wire - July 21, 2006

The Quadriga BeFree System is a fully automated, high-throughput system used to screen blood for common infectious diseases such as human immunodeficiency virus (HIV) and hepatitis. It will be used by large, mid- to high-volume blood bank laboratories to screen donated blood prior to it being used for a blood transfusion. This process helps to ensure donated blood is safe for the transfusion recipient.

"In this industry, we have the opportunity to make a difference in the quality of life of patients while providing our laboratory customers with the innovative solutions they need," said Jim Reid-Anderson, Chairman, President and CEO, Dade Behring. "This new product is a perfect example of meeting our customer's relevant needs and also enhancing patient care."

The Quadriga BeFree System has many features that help to make the testing for infectious diseases safe. Some of these features include: automated patient sample handling and verification, automated barcode identification of patient samples, and continuous monitoring of the instrument's status.

Outside the United States, Dade Behring offers one of the broadest combination of assays and analyzers using microtitre plates for infectious disease testing. BEP(R) Analyzers are used in both medium- to high-volume hospital laboratories. The Quadriga BeFree Systems are designed specifically for high-output automation in large blood banks.

About Dade Behring

With 2005 revenue of nearly $1.7 billion, Dade Behring is the world's largest company solely dedicated to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of laboratories, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the Internet at www.dadebehring.com.

Note: Quadriga BeFree is a registered trademark of Dade Behring Marburg GmbH in the European Community and other countries.

CONTACT: Dade Behring Inc.

Connie DuBois, 847-236-7038

SOURCE: Dade Behring Inc.
060721
BW060711

Copyright © 2006 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .